[Bobo Dioulasso Teaching Hospital day-care hospital: a reference structure for the management of HIV infected patients in Burkina Faso].
OBJECTIVE
The goal of the study was to assess the activity of a multidisciplinary structure for HIV infected patients, two years after the opening of the day hospital.


METHODS
A retrospective observational study of the Bobo Dioulasso day-hospital was made using the ESOPE (Epiconcept, France) software.


RESULTS
In 2002, 147 patients were followed in the Bobo Dioulasso university hospital, 27 (or 18.5 %) of whom were treated with antiretrovirals. Between 2005, opening of the day-hospital, and 2007, the total number of patients increased by 20 %. The number of patients on antiretrovirals rose from 47 to 70 % in the same time. The rate of patients with waved antiretroviral costs rose from 6 to 53 %. Three hundred and eighty-six patients died between 2002 and 2007. 1450 patients were lost to follow-up between 20002 and 2007.


CONCLUSIONS
Two years after its opening, the Bobo Dioulasso day-hospital manages one of the largest HIV cohort in sub-Saharan Africa and has become a reference structure in Burkina Faso. The analysis of this cohort was an opportunity to identify issues concerning HIV patient treatment in 2009.
Fontaine
C
C
Service des maladies infectieuses et tropicales, centre hospitalo-universitaire de Tenon, AP-HP, 4, rue de la Chine, 75020 Paris, France. fontainecamille@hotmail.com
Hema
A
A
Kamboule
E
E
Guiard-Schmid
J-B
JB
Lescure
F-X
FX
Slama
L
L
Pialoux
G
G
Sawadogo
A
A
D000553:Ambulatory Care / Q000458:organization & administration; D044966:Anti-Retroviral Agents / Q000627:therapeutic use; D002050:Burkina Faso; D015331:Cohort Studies; D003631:Day Care, Medical; D005500:Follow-Up Studies; D015658:HIV Infections / Q000188:drug therapy / Q000401:mortality / Q000628:therapy*; D006784:Hospitals, Teaching / Q000458:organization & administration*; D006785:Hospitals, University / Q000458:organization & administration*; D006801:Humans; D015996:Survival Rate; D016896:Treatment Outcome
D044966:Anti-Retroviral Agents